Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients’ Management

The estimation of anti-SARS-CoV-2 IgG antibodies is possibly the best approach to accurately establish the number of infected individuals and the seroprevalence of COVID-19 within a population. Thus, several commercial immunoassays have recently been developed. The purpose of our study was to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Speletas, Matthaios, Kyritsi, Maria A., Vontas, Alexandros, Theodoridou, Aikaterini, Chrysanthidis, Theofilos, Hatzianastasiou, Sophia, Petinaki, Efthimia, Hadjichristodoulou, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785794/
https://www.ncbi.nlm.nih.gov/pubmed/33424863
http://dx.doi.org/10.3389/fimmu.2020.609242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785794/
https://www.ncbi.nlm.nih.gov/pubmed/33424863
http://dx.doi.org/10.3389/fimmu.2020.609242

Ejemplares similares